“… 7 , 8 , 71 , 72 , 73 Research studies have shown that PUE holds intensively neuroprotective effects for various kinds of CNS disorders, including stroke, SAH, TBI, PD, AD, and SCI, through multiple activities, such as antioxidation, anti‐inflammation, and antiapoptosis. 7 , 8 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 PUE can exert brain‐protective effects on ischemia/reperfusion‐mediated brain injury by the suppression of apoptosis/necrosis, autophagy activation, and/or inflammatory response 9 , 10 , 11 , 12 , 13 , 14 , 15 by the promotion of X‐chromosome‐linked inhibitor of apoptosis protein, 15 erythropoietin activity, 13 stimulation of Janus‐activated kinase‐2 and signal transducers and activators of transcription‐3, 12 inhibition of caspase‐3 activity and expression, 15 NF‐κB signal pathway, 11 , 12 Toll‐like receptor‐4, myeloid differentiation factor‐88, 11 and autophagy level. 9 Besides, PUE could also reduce hypobaric hypoxia‐mediated acute lung and cerebrum injury, 74 nickel‐induced liver injury, 75 and diabetes and chronic constriction injury‐induced neuropathic pain by suppressing the activation of the NF‐κB pathway.…”